• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

半乳糖唾液酸贮积症中的组织蛋白酶A缺乏症:对16个家庭的患者和携带者的研究

Cathepsin A deficiency in galactosialidosis: studies of patients and carriers in 16 families.

作者信息

Kleijer W J, Geilen G C, Janse H C, van Diggelen O P, Zhou X Y, Galjart N J, Galjaard H, d'Azzo A

机构信息

Department of Clinical Genetics, Erasmus University, Rotterdam, The Netherlands.

出版信息

Pediatr Res. 1996 Jun;39(6):1067-71. doi: 10.1203/00006450-199606000-00022.

DOI:10.1203/00006450-199606000-00022
PMID:8725271
Abstract

Deficiency of lysosomal protective protein/cathepsin A in humans is the primary cause of galactosialidosis, a lysosomal storage disease characterized by combined deficiency of beta-galactosidase and neuraminidase. We have investigated 20 galactosialidosis patients and nine of their obligate heterozygous parents. A group of 12 patients with the early infantile type of the disease exhibited practically complete absence of cathepsin A activity, whereas eight patients with either the late infantile or the juvenile/adult type had 2-5% residual activity. Highest levels (5%) were present in two patients with milder clinical manifestations and later onset of the disease. In most fibroblast strains, beta-galactosidase activity was 10-15% of normal levels, whereas neuraminidase was reduced to less than 4%. Interestingly, a substantial residual activity (10%) of the latter enzyme was detected in the patient with the mildest phenotype and the highest cathepsin A activity. Heterozygous values for cathepsin A were reduced on average to half of normal levels. However, in two cell strains, the activity was far below control range, and in these cases, neuraminidase activity was severely depressed. Finally, we showed that cathepsin A had considerable activity in chorionic villi and amniocytes, but was deficient in amniocytes from a pregnancy with an affected fetus, indicating the relevance of cathepsin A assay for prenatal diagnosis of galactosialidosis.

摘要

人类溶酶体保护蛋白/组织蛋白酶A缺乏是半乳糖唾液酸贮积症的主要病因,这是一种溶酶体贮积病,其特征是β-半乳糖苷酶和神经氨酸酶联合缺乏。我们研究了20例半乳糖唾液酸贮积症患者及其9名必然的杂合子父母。一组12例早期婴儿型疾病患者几乎完全缺乏组织蛋白酶A活性,而8例晚期婴儿型或青少年/成人型患者有2 - 5%的残余活性。两名临床表现较轻且发病较晚的患者中组织蛋白酶A活性最高(5%)。在大多数成纤维细胞株中,β-半乳糖苷酶活性为正常水平的10 - 15%,而神经氨酸酶活性降至4%以下。有趣的是,在表型最轻且组织蛋白酶A活性最高的患者中检测到后者酶有相当大的残余活性(10%)。组织蛋白酶A的杂合子值平均降至正常水平的一半。然而,在两个细胞株中,其活性远低于对照范围,在这些情况下,神经氨酸酶活性严重降低。最后,我们表明组织蛋白酶A在绒毛膜绒毛和羊水中有相当活性,但来自患病胎儿妊娠的羊水中该酶缺乏,这表明组织蛋白酶A检测对半乳糖唾液酸贮积症产前诊断的相关性。

相似文献

1
Cathepsin A deficiency in galactosialidosis: studies of patients and carriers in 16 families.半乳糖唾液酸贮积症中的组织蛋白酶A缺乏症:对16个家庭的患者和携带者的研究
Pediatr Res. 1996 Jun;39(6):1067-71. doi: 10.1203/00006450-199606000-00022.
2
Early-infantile galactosialidosis: clinical, biochemical, and molecular observations in a new patient.早发性婴儿半乳糖唾液酸贮积症:一名新患者的临床、生化及分子观察
Am J Med Genet. 1996 Aug 23;64(3):453-8. doi: 10.1002/(SICI)1096-8628(19960823)64:3<453::AID-AJMG2>3.0.CO;2-Q.
3
Molecular pathology of galactosialidosis in a patient affected with two new frameshift mutations in the cathepsin A/protective protein gene.组织蛋白酶A/保护蛋白基因发生两个新的移码突变的半乳糖唾液酸贮积症患者的分子病理学
Hum Mutat. 1998;11(6):461-9. doi: 10.1002/(SICI)1098-1004(1998)11:6<461::AID-HUMU7>3.0.CO;2-F.
4
A case of galactosialidosis with a homozygous Q49R point mutation.一例具有纯合Q49R点突变的半乳糖唾液酸贮积症病例。
Brain Dev. 2008 Oct;30(9):595-8. doi: 10.1016/j.braindev.2008.01.012. Epub 2008 Apr 18.
5
Continuous spectrophotometric assay of human lysosomal cathepsin A/protective protein in normal and galactosialidosis cells.正常细胞和半乳糖唾液酸贮积症细胞中人溶酶体组织蛋白酶A/保护蛋白的连续分光光度测定
Anal Biochem. 1995 Sep 20;230(2):303-7. doi: 10.1006/abio.1995.1478.
6
Fetal diagnosis of galactosialidosis (protective protein/cathepsin A deficiency).
Clin Chim Acta. 1997 Oct 31;266(2):75-82. doi: 10.1016/s0009-8981(97)00141-1.
7
[Galactosialidosis].
Ryoikibetsu Shokogun Shirizu. 1998(19 Pt 2):407-10.
8
[Galactosialidosis--protective protein and related enzymes].
Nihon Rinsho. 1995 Dec;53(12):2967-72.
9
Protective protein/cathepsin A loss in cultured cells derived from an early-infantile form of galactosialidosis patients homozygous for the A1184-G transition (Y395C mutation).在源自A1184 - G转换(Y395C突变)纯合子的早发性婴儿型半乳糖唾液酸贮积症患者的培养细胞中保护性蛋白/组织蛋白酶A缺失。
Biochem Biophys Res Commun. 1998 Jun 9;247(1):12-7. doi: 10.1006/bbrc.1998.8659.
10
Cathepsin A/protective protein: an unusual lysosomal multifunctional protein.组织蛋白酶A/保护蛋白:一种独特的溶酶体多功能蛋白。
Cell Mol Life Sci. 1999 Dec;56(11-12):894-907. doi: 10.1007/s000180050482.

引用本文的文献

1
Non-Canonical, Extralysosomal Activities of Lysosomal Peptidases in Physiological and Pathological Conditions: New Clinical Opportunities for Cancer Therapy.溶酶体肽酶在生理和病理条件下的非经典、溶酶体外活性:癌症治疗的新临床机遇
Cells. 2025 Jan 7;14(2):68. doi: 10.3390/cells14020068.
2
Infantile Galactosialidosis with Novel Mutation: An Early Presentation.伴有新突变的婴儿期半乳糖唾液酸贮积症:一种早期表现。
J Pediatr Genet. 2021 Jul 29;12(4):325-328. doi: 10.1055/s-0041-1731776. eCollection 2023 Dec.
3
Identification of embryonic lethal genes in humans by autozygosity mapping and exome sequencing in consanguineous families.
通过近亲家庭中的纯合性定位和外显子组测序鉴定人类胚胎致死基因。
Genome Biol. 2015 Jun 3;16(1):116. doi: 10.1186/s13059-015-0681-6.
4
Clinical utility of whole-exome sequencing in rare diseases: Galactosialidosis.全外显子测序在罕见病中的临床应用:半乳糖唾液酸贮积症
Eur J Med Genet. 2014 Jul;57(7):339-344. doi: 10.1016/j.ejmg.2014.04.005. Epub 2014 Apr 24.
5
LPS-induced cytokine production in human dendritic cells is regulated by sialidase activity.脂多糖诱导的人树突状细胞细胞因子产生受唾液酸酶活性调节。
J Leukoc Biol. 2010 Dec;88(6):1227-39. doi: 10.1189/jlb.1209776. Epub 2010 Sep 8.
6
Clinical aspects of neuropathic lysosomal storage disorders.神经病变溶酶体贮积症的临床方面。
J Inherit Metab Dis. 2010 Aug;33(4):315-29. doi: 10.1007/s10545-010-9079-5. Epub 2010 May 21.
7
The uterine expression of SEC63 gene is up-regulated at implantation sites in association with the decidualization during the early pregnancy in mice.在小鼠妊娠早期,SEC63基因在着床部位的子宫表达上调,且与蜕膜化相关。
Reprod Biol Endocrinol. 2009 Feb 11;7:12. doi: 10.1186/1477-7827-7-12.
8
Transport of human lysosomal neuraminidase to mature lysosomes requires protective protein/cathepsin A.人溶酶体神经氨酸酶向成熟溶酶体的转运需要保护蛋白/组织蛋白酶A。
EMBO J. 1998 Mar 16;17(6):1588-97. doi: 10.1093/emboj/17.6.1588.
9
The atomic model of the human protective protein/cathepsin A suggests a structural basis for galactosialidosis.人类保护性蛋白/组织蛋白酶A的原子模型为半乳糖唾液酸贮积症提出了结构基础。
Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):621-5. doi: 10.1073/pnas.95.2.621.